Genelux Corporation (GNLX) News
Track canonical SquawkNews coverage tagged to GNLX, Genelux Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Genelux reports second-quarter financial results and business updates
Genelux Corporation reports second-quarter financial results and provides business updates, according to the company announcement.
EARNINGS | Aug 13, 2026, 08:20 PM UTC
L
Genelux Announces Publication Of Translational And Clinical Findings From Phase 1b/2 VIRO-15 Trial Of Olvi-Vec-Primed Immunochemotherapy In
Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from Phase 2 VIRO-15 trial - - Data demonstrate Olvi-Vec–mediated modulation of th
COMMODITIES | Jun 30, 2026, 12:02 PM UTC